INS and COVID-19: Although analyzing drug metabolites was out of this study’s scope, a notable fact is that corticosteroids, especially dexamethasone, were used for the treatment of severe COVID-19, and corticosteroids increase hepatic gluconeogenesis, reduce peripheral use of glucose, and increase insulin levels, contributing to hyperglycemia in patients.